Inventor · disambiguated record
Monique Berwaer
Also filed as: BERWAER MONIQUE · BERWAER MONIQUE JENNY MARIE
16 granted patents·14 pending applications·211 citations·filing 1998–2019
92Inventor score
Top patents by PatentIndex Score
30 records- 0193US6699502B1Pharmaceutical compositions for controlled release of active substancesUCB SA·Filed 1998·Granted Mar 2, 2004·125 cites·10 claims
- 0288US7083807B2Pharmaceutical compositions for the controlled release of active substancesUCB SA·Filed 2003·Granted Aug 1, 2006·29 cites·15 claims
- 0384US7226614B2Tablet comprising cetirizine and pseudoephedrineUCB FARCHIM SA·Filed 2005·Granted Jun 5, 2007·8 cites·2 claims
- 0480US7014867B2Tablet comprising cetirizine and pseudoephedrineUCB FARCHIM SA·Filed 2002·Granted Mar 21, 2006·14 cites·92 claims
- 0579US8460712B2Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivateFANARA DOMENICO·Filed 2009·Granted Jun 11, 2013·5 cites·20 claims
- 0674US10172805B2Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivativeFANARA DOMENICO·Filed 2009·Granted Jan 8, 2019·2 cites·23 claims
- 0773US8435564B2Pharmaceutical compositions comprising brivaracetamEECKMAN FREDERIC·Filed 2009·Granted May 7, 2013·3 cites·12 claims
- 0866US8981094B2Piperidine/piperazine derivativesBONGARTZ JEAN-PIERRE ANDRÉ MARC·Filed 2008·Granted Mar 17, 2015·1 cites·28 claims
- 0961US8946229B2FormulationsFANARA DOMENICO·Filed 2008·Granted Feb 3, 2015·0 cites·15 claims
- 1061US6335331B2Pseudopolymorphic forms of 2-[2-[4-[Bis (4-fluorophenyl) methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochlorideUCB SA·Filed 2001·Granted Jan 1, 2002·1 cites·7 claims
- 1158US6455533B1Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrinUCB SA·Filed 1998·Granted Sep 24, 2002·16 cites·18 claims
- 1257US9227935B2Piperidine/piperazine derivativesJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jan 5, 2016·0 cites·13 claims
- 1357US8946228B2Piperidine/piperazine derivativesBONGARTZ JEAN-PIERRE ANDRÉ MARC·Filed 2008·Granted Feb 3, 2015·0 cites·14 claims
- 1456US2020085754A1Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine DerivativeUCB Biophama SPRL·Filed 2019·Application pending·0 cites
- 1555US2019142759A1Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine DerivativeUCB BIOPHARMA SPRL·Filed 2019·Application pending·0 cites
- 1654US2008014264A1Novel pharmaceutical compositions comprising levetiracetamUCB SA·Filed 2007·Application pending·0 cites
- 1749US2002110596A1Pharmaceutical compositions for the controlled release of active substancesFiled 2002·Application pending·0 cites
- 1849US2012010218A1FormulationsFANARA DOMENICO·Filed 2011·Application pending·0 cites
- 1949US2008206331A1Tablet comprising efletirizine and pseudoephedrineUCB SA·Filed 2007·Application pending·0 cites
- 2049US2005038039A1FormulationsFiled 2003·Application pending·0 cites
- 2148US6262057B1Pseudopolymorphic forms of 2-[2-[4-[Bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochlorideUCB SA·Filed 1998·Granted Jul 17, 2001·7 cites·6 claims
- 2246US2016081997A1Piperidine/piperazine derivativesJANSSEN PHARMACEUTICA NV·Filed 2015·Application pending·0 cites
- 2345US2006122194A1Tablet comprising efletirizine and pseudoephedrineUCB FARCHIM SA·Filed 2003·Application pending·0 cites
- 2444US2011027359A1Novel Pharmaceutical Compositions Comprising LevetiracetamUCB SA·Filed 2010·Application pending·0 cites
- 2543US2008194656A1Benzotriazole Derivatives as Cannabinoid Receptor AntagonistsBERWAER MONIQUE JENNY MARIE·Filed 2006·Application pending·0 cites
- 2641US2005171119A1Pharmaceutical formulations with modified releaseUCB SA·Filed 2003·Application pending·0 cites
- 2740US8563036B2Pharmaceutical compositions comprising BrivaracetamEECKMAN FREDERIC·Filed 2010·Granted Oct 22, 2013·0 cites·7 claims
- 2830US2010152277A1Diacylglycerol acyltransferase assayDE WAEPENAERT KATHARINA ANTONIA GERMANIA JOSEPHA M·Filed 2005·Application pending·0 cites
- 2927US2011275693A1Pharmaceutical Compositions Comprising 2-Oxo-1-Pyrrolidine DerivativesUCB PHARMA SA·Filed 2010·Application pending·0 cites
- 3021US10729653B2Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivativesCUYPERS SERGE·Filed 2010·Granted Aug 4, 2020·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →